Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

NYSE Euronext Business Summary For November 2007

Date 05/12/2007

  • Busiest Month Ever for European Cash Markets: +68.3% year-on-year
  • Busiest November Ever for European Derivatives Markets: +38.1% year-on-year
  • NYSE Group Avg. Daily Volume Up 26.8% year-on-year and 53.7% year-to-date
  • NYSE Arca Options: New All-Time Records in Volume and Share of Trading

NYSE Euronext (NYSE Euronext: NYX) reported strong transaction volumes in U.S. and European trading operations for November 2007, highlighted by record activity on Euronext, Liffe and NYSE Arca Options, which is now the third largest options exchange in the U.S.

Average daily volumes of 3.3 billion shares handled(1) on NYSE Group exchanges in November 2007 resulted in year-on-year gains of 26.8%. During the month, 33.6 million transactions(2) were recorded on Euronext cash markets, up 68.3% year-on-year, bringing the total number of transactions registered since the beginning of the year to over 300 million. Liffe registered its busiest November ever, with trading up 38.1% from a year ago. Total volume for equity options trading on NYSE Arca Options reached record levels increasing 72.5% year-on-year. Average daily volume in November improved by 108.7% year-on-year, which included November's new record of 1.97 million contracts traded daily.

NYSE Euronext, with six cash equities and six derivatives exchanges, is the leading and most diversified global exchange group.

                             Cash Products

    Euronext

    --  Euronext's cash markets registered their busiest month ever
        with 33.6 million transactions completed in November 2007, up
        68.3% from the same month last year, representing a record
        average daily volume of 1.5 million transactions.

    --  In total, more than 300 million cash transactions were
        registered on Euronext since the beginning of the year, up
        48.5% from the same period in 2006.

    --  Euronext reported 32.2 million equity transactions in November
        2007, up 69.2% year-on-year. This brought the year-to-date
        total number of transactions to 287 million, up 49.1% versus
        the same period last year.

    --  Year-on-year transactions on Euronext were up 152.7% for ETFs
        and up 52.6% for structured products, including warrants and
        certificates.

    NYSE Group

    --  NYSE Group's exchanges reported 3.3 billion shares handled per
        day in November, up 26.8% year-on-year. Average daily handled
        volume in 2007 is up 53.7% year-to-date compared to 2006.

    --  NYSE Group's operations in NYSE-listed securities reported 2.5
        billion shares handled per day, up 29.3% from the same month
        last year with total volume in 2007 up 19.6% year-to-date.

    --  NYSE Group's operations in ETF trading reported 397 million
        shares handled daily, up 117.7% from the same period last year
        with total volume in 2007 up 64.4% year-to-date. NYSE Arca's
        primary listed ETFs represented 67% of the total assets under
        management and 41% of ETF trading volume for all U.S. ETFs
        year-to-date.

                         Derivatives Products

    Liffe

    --  Liffe, NYSE Euronext's leading futures and options business,
        has had its busiest November ever, with more than 82 million
        futures and options contracts traded, up 38.1% year-on-year.

    --  Interest rate products traded over 45 million contracts in
        November, up 23.3% from the same month last year. Of this, 42
        million contracts were in short-term interest rate (STIR)
        products. Over 459 million interest rate contracts have been
        traded year-to-date, up 26.6% from the same period last year.

    --  Equity products traded 36.3 million contracts in November, up
        62.9% from the same month last year. More that 382 million
        equity contracts have been traded year-to-date, up 34.8% from
        the same period in 2006.

    --  Liffe's Commodity products traded 1.1 million futures and
        options contracts in November, up 33.1% from November last
        year. Volumes are up 29.3% year-to-date.

    --  Bclear, Liffe's pioneering wholesale service, processed 8.9
        million contracts during the month of November, bringing the
        number of contracts processed so far this year to a record 105
        million, up 120.6% from the same period last year.

    NYSE Arca Options

    --  NYSE Arca reported a new all-time record of 1.97 million
        equity options contracts executed daily on average in
        November, up over 300,000 contracts from last month's record
        or 1.66 million contracts traded daily. With nearly 300
        million equity options contracts traded since the beginning of
        the year, NYSE Arca Options volume has increased up 72.5%
        compared to the same period last year.

    --  In approximately one year since its launch, NYSE Arca has
        become the third largest options exchange in the U.S. both for
        overall trading in equity options and the SEC penny pilot in
        November 2007.

    --  With 41.3 million total contracts traded in November, an 8.0%
        increase from the previous record of 38.3 million contracts
        set in October 2007, NYSE Arca Options also achieved a new
        record in overall share of trading, capturing 14.6% of all
        equity options contracts traded, a 2.9% increase year-on-year.

    --  In November, 20.4 million contracts were traded on NYSE Arca
        Options in the SEC options penny pilot, with 17.4 million, or
        85% traded electronically. Share of trading in the 35 penny
        pilot issues in November was 16.5%.

                               Listings

    Euronext

    --  Seven IPOs were added on Euronext's markets in November 2007,
        bringing the total number of IPOs since the beginning of the
        year to a record 125, with EUR 9.4/$13.9 billion raised in
        connection with new listings.

    --  Additionally, seven new ETFs were listed on NextTrack in
        November, bringing the total number of new ETF listings since
        the beginning of the year to 68.

    NYSE Group

    --  The month of November produced a total of 32 new listings on
        NYSE Group markets, including 12 IPOs by operating companies
        on the NYSE, and 1 IPO by an operating company on NYSE Arca.
        During the month, NYSE Group also listed 8 Exchange Traded
        products on NYSE Arca, as well as the new listing of 6 new
        structured products.

    --  Of the 12 new operating companies listed, 8 US domestic
        companies raised a total of EUR 2.8/$4.1 billion in connection
        with listing, while 4 non-US companies raised a total of EUR
        1.2/$1.7 billion in IPO proceeds in connection with listing on
        the NYSE. The new operating company that listed on NYSE Arca
        raised EUR 64.0/$94.5 million with its listing on the
        exchange.

    --  Two new closed-end funds listed in November, raising a total
        of EUR 359.7/$531.0 million.

    Note:

Based on third-quarter 2007 non-GAAP net revenues (excluding activity assessment fees, and liquidity payments, routing and clearing fees) NYSE Euronext revenues from its primary business activities are represented below as a percentage of total net revenues:

    --  Derivatives trading accounts for 25%

    --  European cash trading accounts for 18%

    --  U.S. cash trading accounts for 12%

    --  Market data accounts for 13%

    --  Listing accounts for 12%

    On Nov. 30, 2007: EUR 1 = $1.4761

    Appendix: NYSE Euronext Markets Tables

    About NYSE Euronext

NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007. NYSE Euronext (NYSE Euronext: NYX) operates the world's largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges in six countries, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined $30.3 trillion/EUR 21.3 trillion total market capitalization of listed companies and average daily trading value of approximately $139 billion/EUR 103 billion (as of September 30, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2006 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on June 6, 2007 under No. R.07-0089), 2006 Annual Report on Form 10-K, as amended, and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

(1) Handled shares represent the total number of shares of equity securities internally matched on the NYSE Group's exchanges or routed to and executed at an external market center.

(2) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.

                            NYSE Euronext
                Monthly Volume Summary - Cash Products
----------------------------------------------------------------------


                             Average Daily Volume     Total Volume
                             -----------------------------------------
(Unaudited)                  Nov-07 Nov-06 % Chg  Nov-07 Nov-06 % Chg
                             ------ ------ ------ ------ ------ ------

Number of Trading Days -
 European Markets              22     22            22     22
Number of Trading Days -
 U.S. Markets                  21     21            21     21

European Cash Products
 (trades in thousands)        1,526    907  68.3% 33,574 19,953  68.3%

Equities                      1,463    865  69.2% 32,193 19,031  69.2%
Exchange-Traded Funds             8      3 152.7%    182     72 152.7%
Structured Products              49     32  52.6%  1,073    703  52.6%
Bonds                             6      7 -14.3%    126    147 -14.3%

U.S. Cash Products (shares
 in millions)(2)              3,284  2,590  26.8% 68,964 54,389  26.8%

NYSE Listed Issues (1)

NYSE Group Handled Volume
 (2)                          2,516  1,945  29.3% 52,835 40,848  29.3%
NYSE Group Matched Volume
 (3)                          2,276  1,901  19.7% 47,797 39,924  19.7%
NYSE Group TRF Volume (4)       177      -      -  3,722      -      -
Total NYSE Listed
 Consolidated Volume          4,186  2,787  50.2% 87,909 58,532  50.2%

NYSE Group Share of Total
 Consolidated Volume
Handled Volume (2)            60.1%  69.8%         60.1%  69.8%
Matched Volume (3)            54.4%  68.2%         54.4%  68.2%
TRF Volume (4)                 4.2%      -          4.2%      -

NYSE Arca & Amex Listed
 Issues

NYSE Group Handled Volume
 (2)                            287    135 111.7%  6,019  2,843 111.7%
NYSE Group Matched Volume
 (3)                            243    121  99.9%  5,097  2,550  99.9%
NYSE Group TRF Volume (4)        60      -      -  1,252      -      -
Total NYSE Arca & Amex
 Listed Consolidated Volume     870    348 149.8% 18,275  7,314 149.8%

NYSE Group Share of Total
 Consolidated Volume
Handled Volume (2)            32.9%  38.9%         32.9%  38.9%
Matched Volume (3)            27.9%  34.9%         27.9%  34.9%
TRF Volume (4)                 6.9%      -          6.9%      -

Nasdaq Listed Issues

NYSE Group Handled Volume
 (2)                            481    509  -5.5% 10,110 10,699  -5.5%
NYSE Group Matched Volume
 (3)                            389    421  -7.6%  8,173  8,847  -7.6%
NYSE Group TRF Volume (4)       174      -      -  3,649      -      -
Total Nasdaq Listed
 Consolidated Volume          2,446  1,948  25.6% 51,367 40,912  25.6%

NYSE Group Share of Total
 Consolidated Volume
Handled Volume (2)            19.7%  26.2%         19.7%  26.2%
Matched Volume (3)            15.9%  21.6%         15.9%  21.6%
TRF Volume (4)                 7.1%      -          7.1%      -

Exchange-Traded Funds (1,5)

NYSE Group Handled Volume
 (2)                            397    182 117.7%  8,339  3,830 117.7%
NYSE Group Matched Volume
 (3)                            347    169 104.9%  7,291  3,558 104.9%
NYSE Group TRF Volume (4)        84      -      -  1,754      -      -
Total ETF Consolidated
 Volume                       1,119    407 174.8% 23,506  8,555 174.8%

NYSE Group Share of Total
 Consolidated Volume
Handled Volume (2)            35.5%  44.8%         35.5%  44.8%
Matched Volume (3)            31.0%  41.6%         31.0%  41.6%
TRF Volume (4)                 7.5%      -          7.5%      -


                                               Total Volume
                                           --------------------
(Unaudited)                                YTD 2007 % Chg vs.
                                                      YTD 2006
                                           -------- -----------

Number of Trading Days - European Markets    236
Number of Trading Days - U.S. Markets        231

European Cash Products (trades in
 thousands)                                 300,047       48.5%

Equities                                    287,475       49.1%
Exchange-Traded Funds                         1,452      132.3%
Structured Products                           9,597       34.5%
Bonds                                         1,522       -0.4%

U.S. Cash Products (shares in
 millions)(2)                               671,410       53.7%

NYSE Listed Issues (1)

NYSE Group Handled Volume (2)               519,159       19.6%
NYSE Group Matched Volume (3)               480,385       13.1%
NYSE Group TRF Volume (4)                    13,567           -
Total NYSE Listed Consolidated Volume       787,482       34.6%

NYSE Group Share of Total Consolidated
 Volume
Handled Volume (2)                            65.9%
Matched Volume (3)                            61.0%
TRF Volume (4)                                 1.7%

NYSE Arca & Amex Listed Issues

NYSE Group Handled Volume (2)                48,807       65.2%
NYSE Group Matched Volume (3)                41,980       63.3%
NYSE Group TRF Volume (4)                     4,826           -
Total NYSE Arca & Amex Listed
 Consolidated Volume                        132,881       60.9%

NYSE Group Share of Total Consolidated
 Volume
Handled Volume (2)                            36.7%
Matched Volume (3)                            31.6%
TRF Volume (4)                                 3.6%

Nasdaq Listed Issues

NYSE Group Handled Volume (2)               103,445      -10.8%
NYSE Group Matched Volume (3)                84,235      -11.0%
NYSE Group TRF Volume (4)                    22,957           -
Total Nasdaq Listed Consolidated Volume     507,839        8.3%

NYSE Group Share of Total Consolidated
 Volume
Handled Volume (2)                            20.4%
Matched Volume (3)                            16.6%
TRF Volume (4)                                 4.5%

Exchange-Traded Funds (1,5)

NYSE Group Handled Volume (2)                66,059       64.4%
NYSE Group Matched Volume (3)                58,733       62.2%
NYSE Group TRF Volume (4)                     6,864           -
Total ETF Consolidated Volume               161,868       74.0%

NYSE Group Share of Total Consolidated
 Volume
Handled Volume (2)                            40.8%
Matched Volume (3)                            36.3%
TRF Volume (4)                                 4.2%
                            NYSE Euronext
----------------------------------------------------------------------
            Monthly Volume Summary - Derivatives Products
----------------------------------------------------------------------


                           Average Daily Volume      Total Volume
                           -------------------- ----------------------
(Unaudited; contracts in   Nov-07 Nov-06 % Chg  Nov-07  Nov-06  % Chg
 thousands)
                           ------ ------ ------ ------- ------- ------

Number of Trading Days -
 European Markets            22     22            22      22
Number of Trading Days -
 U.S. Markets                21     21            21      21

European Derivatives
 Products                   3,767  2,727  38.1%  82,868  59,985  38.1%

Total Interest Rate
 Products                   2,060  1,671  23.3%  45,329  36,758  23.3%

    Short Term Interest
     Rate Products          1,915  1,541  24.3%  42,141  33,910  24.3%
    Medium and Long Term
     Interest Rate
     Products                 145    129  11.9%   3,188   2,849  11.9%

Total Equity Products (6)   1,652  1,014  62.9%  36,333  22,310  62.9%

    Individual Equity
     Products                 945    529  78.5%  20,792  11,649  78.5%
    Equity Index Products     706    485  45.8%  15,541  10,661  45.8%

      of which Bclear         405    124 226.5%   8,902   2,726 226.5%
          Individual
           Equity Products    260     72 261.5%   5,710   1,579 261.5%
          Equity Index
           Products           145     52 178.3%   3,192   1,147 178.3%

Commodity Products             52     39  33.1%   1,145     860  33.1%

Currency Products               3      3   8.3%      61      56   8.3%

U.S. Derivatives Products
 - Equity Options (7)

NYSE Arca Options
 Contracts                  1,966    942 108.7%  41,291  19,788 108.7%
Total Consolidated Options
 Contracts                 13,469  8,021  67.9% 282,853 168,432  67.9%

NYSE Group Share of Total   14.6%  11.7%          14.6%   11.7%



                                                     Total Volume
                                                 ---------------------
(Unaudited; contracts in thousands)               YTD 2007  % Chg vs.
                                                             YTD 2006
                                                 ---------- ----------

Number of Trading Days - European Markets           236
Number of Trading Days - U.S. Markets               231

European Derivatives Products                       881,889      30.0%

Total Interest Rate Products                        486,891      26.6%

         Short Term Interest Rate Products          459,660      26.6%
         Medium and Long Term Interest Rate
          Products                                   27,231      25.9%

Total Equity Products (6)                           382,884      34.8%

         Individual Equity Products                 237,987      38.7%
         Equity Index Products                      144,896      28.8%

           of which Bclear                          105,757     120.6%
               Individual Equity Products            85,578     144.4%
               Equity Index Products                 20,180      56.0%

Commodity Products                                   11,647      29.3%

Currency Products                                       468     -33.0%

U.S. Derivatives Products - Equity Options (7)

NYSE Arca Options Contracts                         299,938      72.5%
Total Consolidated Options Contracts              2,373,522      40.5%

NYSE Group Share of Total                             12.6%       2.3%


(1)Includes all volume executed in NYSE Group crossing sessions.
(2)Represents the total number of shares of equity securities and ETFs
    internally matched on the NYSE Group's exchanges or routed to and
    executed at an external market center. NYSE Arca routing includes
    odd-lots.
(3)Represents the total number of shares of equity securities and ETFs
    executed on the NYSE Group's exchanges.
(4)Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility
    (TRF).
(5)Data included in previously identified categories.
(6)Includes all trading activities for Bclear, Euronext.liffe's
    clearing service for wholesale equity derivatives.
(7)Includes trading in U.S. equity options contracts, not equity-index
    options.
   Source: NYSE Euronext, Options Clearing Corporation and
    Consolidated Tape as reported for equity securities.
   All trading activity is single-counted, except European cash
    trading which is double counted to include both buys and sells.